VERTEX PHARMACEUTICALS INC / MA Earnings Per Share Diluted

• VERTEX PHARMACEUTICALS INC / MA showed an increase of +836.5% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from VERTEX PHARMACEUTICALS INC / MA's annual report (Form 10-K), filed with the SEC on February 13, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2013: $1.43 (loss) per share | Q2 2013: $0.26 (loss) per share | Q3 2013: $0.54 (loss) per share | Q4 2013: $0.19 per share | Q1 2014: $1.00 (loss) per share | Q2 2014: $0.68 (loss) per share | Q3 2014: $0.72 (loss) per share | Q1 2015: $0.83 (loss) per share | Q2 2015: $0.78 (loss) per share | Q3 2015: $0.39 (loss) per share | Q1 2016: $0.17 (loss) per share | Q2 2016: $0.26 (loss) per share | Q3 2016: $0.16 (loss) per share | Q4 2016: $0.13 per share | Q1 2017: $0.99 per share | Q2 2017: $0.07 per share | Q3 2017: $0.41 (loss) per share | Q4 2017: $0.39 per share | Q1 2018: $0.81 per share | Q2 2018: $0.80 per share | Q3 2018: $0.50 per share | Q4 2018: $5.97 per share | Q1 2019: $1.03 per share | Q2 2019: $1.03 per share | Q3 2019: $0.22 per share | Q4 2019: $2.23 per share | Q1 2020: $2.29 per share | Q2 2020: $3.18 per share | Q3 2020: $2.53 per share | Q4 2020: $2.30 per share | Q1 2021: $2.49 per share | Q2 2021: $0.26 per share | Q3 2021: $3.28 per share | Q1 2022: $2.96 per share | Q2 2022: $3.13 per share | Q3 2022: $3.59 per share | Q1 2023: $2.69 per share | Q2 2023: $3.52 per share | Q3 2023: $3.97 per share | Q1 2024: $4.21 per share | Q2 2024: $13.92 (loss) per share | Q3 2024: $4.01 per share | Q1 2025: $2.49 per share | Q2 2025: $3.99 per share | Q3 2025: $4.20 per share.
• Over the full 18 years of available data (2008 to 2025), VERTEX PHARMACEUTICALS INC / MA's Earnings Per Share Diluted has grown by 568.5%.
• Historical annual values: Fiscal year 2025: $15.32 per share | Fiscal year 2024: $2.08 (loss) per share | Fiscal year 2023: $13.89 per share | Fiscal year 2022: $12.82 per share | Fiscal year 2021: $9.01 per share | Fiscal year 2020: $10.29 per share | Fiscal year 2019: $4.51 per share | Fiscal year 2018: $8.09 per share | Fiscal year 2017: $1.04 per share | Fiscal year 2016: $0.46 (loss) per share | Fiscal year 2015: $2.31 (loss) per share | Fiscal year 2014: $3.14 (loss) per share | Fiscal year 2013: $1.98 (loss) per share | Fiscal year 2012: $0.50 (loss) per share | Fiscal year 2011: $0.14 per share | Fiscal year 2010: $3.77 (loss) per share | Fiscal year 2009: $3.71 (loss) per share | Fiscal year 2008: $3.27 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026